Bacteriostatic water for injection, USP 0.9% benzyl alcohol preservative
twice-daily injections typical for injectable protocols No refrigeration needed (capsules stable at room temperature) Convenient for travel and busy schedules Dietary supplement status (no prescription required) Injectable Characteristics: Potentially higher bioavailability reaching systemic circulation (comparative human data does not exist) Established user base with extensive anecdotal reports Ability to perform local injection near injury sites Dosing protocols from practitioner guidance more available Consideration: Oral BPC-157 suits needle-averse beginners prioritizing convenience
Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, 125 (7), 441448
While the overall frequency of liver enzyme elevations across the over 1,400 participant safety database of danuglipron is in-line with approved agents in the class, a single asymptomatic participant in one of the dose-optimization studies experienced potential drug-induced liver injury which resolved after discontinuation of danuglipron
PLoS One 10 , e0141743, (2015)
